METRO (St.) Aktie

11,09EUR
-0,02EUR
-0,14%
27.10.2021

WKN: BFB001 / ISIN: DE000BFB0019

  Kaufen  
Verkaufen
oder
Werbung

Times and Sales (XETRA)

ZeitKursUmsatz
Zur Zeit stehen keine Daten zur Verfügung
weiter
Werbung

Aktuelle News zu

04:15 UhrMagnesium Market Size to Grow by USD 844.74 Million| High Demand for Steel From Various End-use Industries to Boost Market Growth | 17,000+ Technavio Research Reports
04:11 UhrStarlight Investments gründet Joint Venture mit zwei globalen institutionellen Partnern und erwirbt zwei getrennte Mehrfamilienportfolios im Wert von 1,3 Mrd. US-Dollar
04:00 UhrLow Voltage Motors Market to Grow by USD 4.99 Bn |Industry Analysis, Market Trends, Market Growth, Opportunities, and Forecast|17,000+ Technavio Research Reports
04:00 UhrTORANOTEC Named to 2021 Inclusive Fintech 50
04:00 UhrTravel Confidence, Sustainability and Curated Experiences Are Priorities for New Travellers
03:47 UhrNoble Completes Acquisition of Federal Resources
03:40 UhrCoway Honored with Four Accolades at Good Design Award
03:33 UhrBlackground Records 2.0 Announces 2 Sisters as President and Head of Publicity
03:32 UhrStagwell Agencies Take Home Honors at Association of National Advertisers 2021 Multicultural Excellence Awards
03:32 UhrStagwell Agencies Take Home Honors at Association of National Advertisers 2021 Multicultural Excellence Awards
03:28 UhrTrotz Kritik in Sachen Datenschutz: Google will weiter im Gesundheitssektor arbeiten
03:15 UhrTesla-Konkurrenz aus der Smartphone-Branche: 2024 sollen die ersten Xiaomi-Elektrofahrzeuge vom Band rollen
03:15 UhrMagnesite Market Size to Grow by USD 1.25 bn from 2020 to 2025 | Growing Demand for Refractories from the Steel Industry to Boost Market Growth | 17,000+ Technavio Research Reports
03:08 UhrViewSonic Introduces ViewBoard Box to Transform Classrooms into Immersive Digital Learning Spaces in Seconds
03:00 UhrIreland's John Mulcahy Recognized With Lifetime Achievement Award
03:00 UhrData from Phase 1/2a study of RM-1929 Photoimmunotherapy in Patients with Recurrent Head and Neck Squamous Cell Carcinoma was Published in Head and Neck
03:00 UhrCoway Honored with Four Accolades at Good Design Award
03:00 UhrSocial Robots Market Size to Grow by USD 1.10 bn from 2020 to 2025 | Technological Advances in Social Robots to Boost Market Growth | 17,000+ Technavio Research Reports
02:52 UhrShutterstock stellt neue Workflow-Anwendungen, datenfähige Funktionen und flexible Abonnements für verbessertes kreatives Schaffen vor
02:51 UhrMY01 Continuous Compartmental Pressure Monitor granted Breakthrough Device Designation from the FDA
02:51 UhrMY01 Continuous Compartmental Pressure Monitor granted Breakthrough Device Designation from the FDA
02:50 UhrCascades Inc. Announces Modified Dutch Auction Tender Offers for up to US$200 Million of its 5.375% Senior Notes Due 2028 and 5.125% Senior Notes Due 2026
02:50 UhrCascades Inc. Announces Modified Dutch Auction Tender Offers for up to US$200 Million of its 5.375% Senior Notes Due 2028 and 5.125% Senior Notes Due 2026
02:39 UhrSpaceX vs. Blue Origin & Virgin Galactic: Physiker nennt einen klaren Gewinner
02:30 UhrWuXi Biologics Completes GMP Inspection by Health Canada for Drug Substance Facility
02:29 UhrGrupo Elektra Announces Remarkable 1.5-Times Growth In EBITDA, To Ps.5,557 Million In The Third Quarter Of 2021
02:29 UhrTrending Today on Fox Business Features Entrepreneurs Making Marketplace Headlines
02:18 UhrGrupo Comercial Chedraui, S.A.B. de C.V. Third Quarter 2021 Results
02:03 UhrScientific Games Announces Sale of Lottery Business to Brookfield Business Partners for $6.05 Billion
02:00 UhrInnovent and NeoCura Announce Strategic Collaboration to Study the Combination Therapy of Sintilimab and Neoantigen Vaccine NEO_PLIN2101 for Cancer Treatment in China
02:00 UhrTricor Group & FutureCFO Co-release 2021 CFO Global Insights Survey Revealing Top Priorities for Finance & Accounting Leaders in the Post-COVID Era
02:00 UhrTHOMAS SABO receives certification from the Responsible Jewellery Council
02:00 UhrInnovent and NeoCura Announce Strategic Collaboration to Study the Combination Therapy of Sintilimab and Neoantigen Vaccine NEO_PLIN2101 for Cancer Treatment in China
02:00 UhrElevenEs receives investment and support from EIT InnoEnergy to build a battery gigafactory near Serbia's lithium deposit
02:00 UhrRS Components industrial electronics solutions help Australian and New Zealand industries get ahead with IIOT
01:38 UhrRECONAFRICA DEADLINE: Reconnaissance Energy Africa Ltd. f/k/a Lund Enterprises Corp. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - RECAF; LGDOF
01:35 Uhr360VUZ Scales Its Operations In Saudi Arabia Building On The Metaverse
01:29 UhrCPSC Posts Recalls to its Web Site
01:22 UhrEmbrey Acquires Retreat at Chelsea Park in Selma, TX
01:18 UhrElite immigration practitioner joins Fragomen
01:15 UhrPrologis Hosts Inaugural "Breaking New Ground" Event at Global Headquarters in San Francisco
01:14 UhrLundin Mining Third Quarter Results
01:12 UhrElkhart County To Provide Tablets To Incarcerated Individuals Through New Partnership With Securus Technologies
01:01 Uhr3Q21 Results: Telefônica Brasil S.A.
01:01 UhrPowermat Technologies Selects J21 Corporation as Official Master Distributor for the Company's Wireless Charging Technology as it Expands to Japanese Market
01:00 UhrTeamsters Local 533 Puts Keolis On Notice
01:00 UhrAUTOCRYPT Demonstrates Interoperability in China's Largest "Four Layers" C-V2X Demonstration Following Showcase at 2021 China-SAE Congress and Exhibition
00:47 UhrChampion Iron Reports Robust Results for its FY2022 Second Quarter, Advances the Bloom Lake Phase II Expansion Project and Redeems Remaining Preferred Shares
00:36 UhrTerex Corporation Releases Environmental, Social And Governance Report Highlighting Progress On ESG Priorities
00:35 UhrOhio Valley Banc Corp. Reports 3rd Quarter Earnings
finanzen.net zero
finanzen.net zero

Oskar

ETF-Sparplan

Oskar ist der einfache und intelligente ETF-Sparplan. Er übernimmt die ETF-Auswahl, ist steuersmart, transparent und kostengünstig.
Zur klassischen Ansicht wechseln